Insider Trading & Ownership - Kieffer Tara Lynn

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Kieffer Tara Lynn
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-06-17
Sale
2024-06-17
8:38 pm
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Chief Product Strategy Officer
7,266$12.33$89,59032,341
(Direct)
View
2023-12-05
Sale
2023-12-06
8:29 pm
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Sr. VP, New Prod. Strat. & Dev
2,125$9.63$20,46437,260
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-12
Tax Withholding
2024-02-14
8:21 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Chief Product Strategy Officer
973$12.4139,607
(Direct)
View
2024-02-12
Option Award
2024-02-14
8:21 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Chief Product Strategy Officer
3,320$039,607
(Direct)
View
2023-12-01
Tax Withholding
2023-12-05
9:21 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Sr. VP, New Prod. Strat. & Dev
753$9.4939,385
(Direct)
View
2023-11-22
Option Award
2023-11-22
5:12 pm
N/A
2033-11-22
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Sr. VP, New Prod. Strat. & Dev
83,000$083,000
(Direct)
View
2023-02-13
Option Award
2023-02-15
9:51 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Sr. VP, New Product Dev.
20,997$040,138
(Direct)
View
2023-02-13
Tax Withholding
2023-02-15
9:51 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Sr. VP, New Product Dev.
6,725$52.7740,138
(Direct)
View
2022-12-01
Tax Withholding
2022-12-05
7:27 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Sr. VP, New Product Dev.
498$44.3325,866
(Direct)
View
2022-11-23
Option Award
2022-11-28
6:38 pm
N/A
2032-11-23
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Sr. VP, New Product Dev.
58,500$066,364
(Direct)
View
2022-02-14
Tax Withholding
2022-02-15
9:51 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Sr. VP, New Product Dev.
552$62.497,864
(Direct)
View
2022-02-14
Option Award
2022-02-15
9:51 pm
N/A
N/A
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Sr. VP, New Product Dev.
1,616$07,864
(Direct)
View
2021-11-19
Option Award
2021-11-23
8:00 pm
N/A
2031-11-19
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Sr. VP, New Product Dev.
35,200$035,200
(Direct)
View
2020-12-07
Option Award
2020-12-08
7:16 pm
N/A
2030-12-07
ENANTA PHARMACEUTICALS INCENTAKieffer Tara Lynn
Sr. VP, New Product Dev.
65,000$065,000
(Direct)
View